Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GPI-anchor synthesis.

T Kinoshita1, J Takeda

  • 1Department of Immunoregulation, Research Institute for Microbial Diseases, Osaka University, 3-I Yamada-oka, Suita, Osaka 565, Japan.

Parasitology Today (Personal Ed.)
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia.

Leukemia·2017
Same author

Donor cell-derived transient abnormal myelopoiesis as a specific complication of umbilical cord blood transplantation.

Bone marrow transplantation·2017
Same author

Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia.

Blood cancer journal·2017
Same author

Feasibility of salvage cord blood transplantation following fludarabine, melphalan and low-dose TBI for graft rejection after hematopoietic stem cell transplantation.

Bone marrow transplantation·2016
Same author

Active and passive exposure to tobacco smoke in relation to insulin sensitivity and pancreatic β-cell function in Japanese subjects.

Diabetes & metabolism·2014
Same author

Screening of diabetes of youth for hepatocyte nuclear factor 1 mutations: clinical phenotype of HNF1β-related maturity-onset diabetes of the young and HNF1α-related maturity-onset diabetes of the young in Japanese.

Diabetic medicine : a journal of the British Diabetic Association·2014
Same journal

Immune effector mechanisms in parasitic infections.

Parasitology today (Personal ed.)·2006
Same journal

Nitric oxide in health and disease.

Parasitology today (Personal ed.)·2006
Same journal

Infection, oxford general practice series 40.

Parasitology today (Personal ed.)·2006
Same journal

Parasitism and the platyhelminthes.

Parasitology today (Personal ed.)·2006
Same journal

Reply.

Parasitology today (Personal ed.)·2006
Same journal

Waterborne cryptosporidiosis and the need for legislation.

Parasitology today (Personal ed.)·2006
See all related articles

The glycosyl phosphatidylinositol (GPI) anchor is vital for membrane proteins in eukaryotes. Its conserved biosynthetic pathway, with identified genes, offers potential targets for anti-parasitic chemotherapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Parasitology

Background:

  • The glycosyl phosphatidylinositol (GPI) anchor is a crucial post-translational modification for many eukaryotic membrane proteins.
  • Its core structure and biosynthesis are conserved across diverse species, including parasitic protozoa.

Purpose of the Study:

  • To review the GPI-anchor biosynthetic pathway and its associated genes.
  • To highlight the potential of this pathway as a target for novel anti-parasitic chemotherapy.

Main Methods:

  • Isolation of genes involved in mammalian GPI-anchor biosynthesis using mutant cell lines and expression cloning.
  • Elucidation of the conserved structure and biosynthetic pathway of the GPI anchor core.

Main Results:

Related Experiment Videos

  • Identification of genes critical for GPI-anchor biosynthesis, including one linked to paroxysmal nocturnal hemoglobinuria.
  • Confirmation of conserved GPI-anchor core structure and biosynthesis across species.

Conclusions:

  • The GPI-anchor biosynthetic pathway presents a promising avenue for developing new anti-parasitic drugs.
  • Understanding species-specific modifications and pathway differences is key for targeted chemotherapy.